Literature DB >> 24905792

Laparoscopic splenectomy for primary immune thrombocytopenia: clinical outcome and prognostic factors.

Jorge Montalvo1, David Velazquez, Juan P Pantoja, Mauricio Sierra, Xavier López-Karpovitch, Miguel F Herrera.   

Abstract

BACKGROUND: Laparoscopic splenectomy (LS) is considered the standard treatment for patients with refractory primary immune thrombocytopenia (ITP). PATIENTS AND METHODS: All patients with ITP who underwent LS during the last 17 years and who had a minimum follow-up of 1 year were included. Several perioperative variables such as age, platelet count, and duration of preoperative therapy were recorded and analyzed, looking for potential predictive variables of clinical response.
RESULTS: In total, 150 patients were included: 108 (72%) women and 42 (28%) men, with a mean age of 37.3±15.8 years. In the evaluation 1 year after surgery, 133 (88.7%) patients had achieved complete response, 4 (2.7%) had a response, and in 13 (8.6%) there was no response. None of the analyzed preoperative variables was identified as a predictive factor of response at 1 year. Immediate responders after surgery (≥150,000 platelets/mL during the first week) had a higher platelet count and rate of complete response at 1 year (94.2%).
CONCLUSIONS: LS has a high success rate in patients with refractory ITP. Potential predictive indicators of success remain to be determined.

Entities:  

Mesh:

Year:  2014        PMID: 24905792     DOI: 10.1089/lap.2013.0267

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  9 in total

Review 1.  Evidence-based management of immune thrombocytopenia: ASH guideline update.

Authors:  Cindy E Neunert; Nichola Cooper
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Laparoscopic splenectomy is a better surgical approach for spleen-relevant disorders: a comprehensive meta-analysis based on 15-year literatures.

Authors:  Ji Cheng; Kaixiong Tao; Peiwu Yu
Journal:  Surg Endosc       Date:  2016-02-19       Impact factor: 4.584

3.  Laparoscopic splenectomy for immune thrombocytopenia (ITP): long-term outcomes of a modern cohort.

Authors:  Luciano Tastaldi; David M Krpata; Ajita S Prabhu; Clayton C Petro; Ivy N Haskins; Arielle J Perez; Hemasat Alkhatib; Iago Colturato; Chao Tu; Alan Lichtin; Michael J Rosen; Steven Rosenblatt
Journal:  Surg Endosc       Date:  2018-07-09       Impact factor: 4.584

Review 4.  Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges.

Authors:  Dong Zheng; Chen-Song Huang; Shao-Bin Huang; Chao-Xu Zheng
Journal:  World J Gastrointest Endosc       Date:  2016-09-16

5.  American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Authors:  Cindy Neunert; Deirdra R Terrell; Donald M Arnold; George Buchanan; Douglas B Cines; Nichola Cooper; Adam Cuker; Jenny M Despotovic; James N George; Rachael F Grace; Thomas Kühne; David J Kuter; Wendy Lim; Keith R McCrae; Barbara Pruitt; Hayley Shimanek; Sara K Vesely
Journal:  Blood Adv       Date:  2019-12-10

6.  Predictive Factors for Success of Laparoscopic Splenectomy for ITP.

Authors:  Áron Nyilas; Attila Paszt; Bernadett Borda; Zsolt Simonka; Szabolcs Ábrahám; Ágnes Bereczki; Dóra Földeák; György Lázár
Journal:  JSLS       Date:  2018 Oct-Dec       Impact factor: 2.172

Review 7.  Management of immune thrombocytopenia: 2022 update of Korean experts recommendations.

Authors:  Young Hoon Park; Dae-Young Kim; Seongkoo Kim; Young Bae Choi; Dong-Yeop Shin; Jin Seok Kim; Won Sik Lee; Yeung-Chul Mun; Jun Ho Jang; Jong Wook Lee; Hoon Kook; On Behalf Of Korean Aplastic Anemia Working Party
Journal:  Blood Res       Date:  2022-03-31

8.  Laparoscopic splenectomy for immune thrombocytopenia in patients with a very low platelet count.

Authors:  Anna Zychowicz; Dorota Radkowiak; Anna Lasek; Piotr Małczak; Jan Witowski; Piotr Major; Marcin Strzałka; Jan Kulawik; Andrzej Budzyński; Michał Pędziwiatr
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-05-16       Impact factor: 1.195

9.  Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study.

Authors:  Yimei Feng; Yunshuo Xiao; Hongju Yan; Ping Wang; Wen Zhu; Kaniel Cassady; Zhongmin Zou; Kaifa Wang; Ting Chen; Yao Quan; Zheng Wang; Shijie Yang; Rui Wang; Xiaoping Li; Lei Gao; Cheng Zhang; Yao Liu; Peiyan Kong; Li Gao; Xi Zhang
Journal:  Front Med (Lausanne)       Date:  2020-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.